# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...
Novel Supplement Shown to Address Signs and Symptoms of Dry Eyes, All Primary Endpoints AchievedBausch + Lomb Corporation (TSX:...
RBC Capital analyst Douglas Miehm maintains Bausch & Lomb (NYSE:BLCO) with a Outperform and lowers the price target from...
Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb (NYSE:BLCO) with a In-Line and raises the price target fr...
Barclays analyst Matt Miksic maintains Bausch & Lomb (NYSE:BLCO) with a Equal-Weight and raises the price target from $1...
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported m...
Bausch + Lomb achieves Q4 2023 sales of $1.173 billion, exceeding expectations with an 18% YoY growth. CEO Brent Saunders antic...